Athenex Aktie - ATNX

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,2031

Gebot

0,2032

Fragen

0,2033

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,2031

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process

To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings Company Has Sufficient Resources to...

Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO

Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and...

Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update

Exploring a range of strategic alternatives Revenues from product sales from continued operations increased...

Athenex Announces a Reverse Stock Split

BUFFALO, N.Y., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical...

Athenex Announces MHRA Decision on Oral Paclitaxel

MHRA denies Oral Paclitaxel for metastatic breast cancer based solely on chemistry, manufacturing and control...

Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer

BUFFALO, N.Y., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ATNX - Frequently Asked Questions (FAQ)

What is the current Athenex share price?

The current share price of Athenex is US$ 0,2031

What is the 1 year trading range for Athenex share price?

Athenex has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
RDUSRadius Recycling Inc	US$ 27,902 (104,26%)	8,53M
BONBon Natural Life Ltd	US$ 1,40 (90,29%)	84M
SUNESUNation Energy Inc	US$ 0,5213 (62,96%)	513,96M
WHLRLWheeler Real Estate Investment Trust Inc	US$ 255,00 (39,80%)	222
AAOIApplied Optoelectronics Inc	US$ 22,105 (39,29%)	17,01M
GLSTUGlobal Star Acquisition Inc	US$ 2,00 (-69,23%)	421
CURRCurrenc Group Inc	US$ 2,03 (-41,33%)	1,42M
ADTXAditxt Inc	US$ 0,0201 (-39,82%)	240,2M
HEPAHepion Pharmaceuticals Inc	US$ 0,0228 (-39,68%)	161,52M
WKSPWorksport Ltd	US$ 0,36205 (-35,45%)	4,96M
SUNESUNation Energy Inc	US$ 0,5213 (62,96%)	513,96M
NVDANVIDIA Corporation	US$ 121,67 (5,27%)	277,56M
ADTXAditxt Inc	US$ 0,0201 (-39,82%)	240,2M
HEPAHepion Pharmaceuticals Inc	US$ 0,0228 (-39,68%)	161,52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9,225 (7,64%)	160,21M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Athenex Inc (ATNX)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ATNX Neueste Nachrichten

Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process

Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO

Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update

Athenex Announces a Reverse Stock Split

Athenex Announces MHRA Decision on Oral Paclitaxel

Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer

Athenex Exits 503B Sterile Compounding Business

Athenex Announces Positive Results of Special Stockholder Meeting

Athenex Announces Closing of the Sale of its China API Business

Athenex Announces Receipt of Positive Nasdaq Listing Determination

ATNX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Athenex Inc (ATNX) Börsenkurse

Athenex Inc (ATNX)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ATNX Neueste Nachrichten

Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process

Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCO

Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update

Athenex Announces a Reverse Stock Split

Athenex Announces MHRA Decision on Oral Paclitaxel

Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer

Athenex Exits 503B Sterile Compounding Business

Athenex Announces Positive Results of Special Stockholder Meeting

Athenex Announces Closing of the Sale of its China API Business

Athenex Announces Receipt of Positive Nasdaq Listing Determination

ATNX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS